HuGE Literature Finder
Records
1
-
7
Pharmacogenetics of antiemetics for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis. Critical reviews in oncology/hematology 2020 May 149 102939. Eliasen Astrid, Dalhoff Kim, Mathiasen René, Schmiegelow Kjeld, Rechnitzer Catherine, Schelde Astrid Blicher, Perwitasari Dyah Aryani, Tsuji Daiki, Brok Jesp |
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.
![]() The Lancet. Oncology 2016 Aug . Gharahkhani Puya, Fitzgerald Rebecca C, Vaughan Thomas L, Palles Claire, Gockel Ines, Tomlinson Ian, Buas Matthew F, May Andrea, Gerges Christian, Anders Mario, Becker Jessica, Kreuser Nicole, Noder Tania, Venerito Marino, Veits Lothar, Schmidt Thomas, Manner Hendrik, Schmidt Claudia, Hess Timo, Böhmer Anne C, Izbicki Jakob R, Hölscher Arnulf H, Lang Hauke, Lorenz Dietmar, Schumacher Brigitte, Hackelsberger Andreas, Mayershofer Rupert, Pech Oliver, Vashist Yogesh, Ott Katja, Vieth Michael, Weismüller Josef, Nöthen Markus M, , , , Attwood Stephen, Barr Hugh, Chegwidden Laura, de Caestecker John, Harrison Rebecca, Love Sharon B, MacDonald David, Moayyedi Paul, Prenen Hans, Watson R G Peter, Iyer Prasad G, Anderson Lesley A, Bernstein Leslie, Chow Wong-Ho, Hardie Laura J, Lagergren Jesper, Liu Geoffrey, Risch Harvey A, Wu Anna H, Ye Weimin, Bird Nigel C, Shaheen Nicholas J, Gammon Marilie D, Corley Douglas A, Caldas Carlos, Moebus Susanne, Knapp Michael, Peters Wilbert H M, Neuhaus Horst, Rösch Thomas, Ell Christian, MacGregor Stuart, Pharoah Paul, Whiteman David C, Jankowski Janusz, Schumacher Johann |
Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer. Breast cancer research and treatment 2014 Feb 144 (1): 123-31. Pud Dorit, Har-Zahav Gil, Laitman Yael, Rubinek Tami, Yeheskel Adva, Ben-Ami Sarah, Kaufman Bella, Friedman Eitan, Symon Zvi, Wolf I |
Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids. European journal of cancer (Oxford, England : 1990) 2011 Jul 47 (11): 1682-91. Laugsand Eivor A, Fladvad Torill, Skorpen Frank, Maltoni Marco, Kaasa Stein, Fayers Peter, Klepstad P |
Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain 2011 May 152 (5): 1139-45. Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers P M, Kaasa S, , |
Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy. Journal of cancer research and clinical oncology 2008 Oct 134 (10): 1079-86. Fasching P A, Kollmannsberger B, Strissel P L, Niesler B, Engel J, Kreis H, Lux M P, Weihbrecht S, Lausen B, Bani M R, Beckmann M W, Strick |
Investigation of HTR3C mutations for association with 5HT(3) receptor antagonist anti-emetic efficacy. Pharmacogenomics 2008 Aug 9 (8): 1027-33. Ward Michael B, Kotasek Dusan, McKinnon Ross |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 30, 2023
- Content source: